US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist
  • 11.970
  • +0.020+0.17%
Trading Mar 27 13:48 ET
324.62MMarket Cap-3.99P/E (TTM)

About Arcturus Therapeutics Company

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Company Profile

SymbolARCT
Company NameArcturus Therapeutics
Listing DateMay 22, 2013
Founded2013
CEOMr. Joseph E. Payne
MarketNASDAQ
Employees176
Fiscal Year Ends12-31
Address10628 Science Center Drive,Suite 250
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-900-2660
Websitehttp://www.arcturusrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Joseph E. Payne
  • Director, President and Chief Executive Officer
  • 4.89M
  • Lance Kurata
  • Chief Legal Officer
  • 2.10M
  • Dr. Padmanabh Chivukula
  • Chief Scientific Officer and Chief Operating Officer
  • 3.18M
  • Andrew H. Sassine
  • Director, Chief Financial Officer and Principal Accounting Officer
  • 2.18M
  • Dr. Moncef M. Slaoui, PhD
  • Chairman of the Board
  • --
  • James F. Barlow
  • Independent Director
  • 330.50K
  • Dr. Peter C. Farrell, A.M.,PhD
  • Independent Director
  • 328.00K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 318.00K
  • Dr. John H. Markels, PhD
  • Independent Director
  • 320.50K
  • Dr. Jing L. Marantz, M.D.,PhD
  • Independent Director
  • 318.00K
  • Dr. Edward W. Holmes
  • Independent Director
  • 325.50K
  • Joseph Robert
  • Controller
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
277.750
Petroleo Brasileiro SA Petrobras
PBR
14.465
Apple
AAPL
223.500
4
Vale SA
VALE
10.189
5
KB Home
KBH
59.440
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Earnings Season Underway
Earnings season is here. What to know?